Carmel Capital Partners’s Pfizer PFE Stock Holding History

Carmel Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,751	Closed	-$91.3K	–	537
2023 Q3	$91.3K	Buy	2,751 +2,103	+325%	+$74.4K	0.04%	206
2023 Q2	$23.8K	Sell	648 -2,623	-80%	-$102K	0.01%	242
2023 Q1	$133K	Sell	3,271 -3,746	-53%	-$162K	0.08%	162
2022 Q4	$360K	Sell	7,017 -4,286	-38%	-$205K	0.25%	84
2022 Q3	$495K	Hold	11,303	–	–	0.48%	57
2022 Q2	$593K	Sell	11,303 -2,465	-18%	-$126K	0.55%	56
2022 Q1	$713K	Sell	13,768 -261	-2%	-$13.5K	0.6%	52
2021 Q4	$828K	Buy	+14,029	New	+$695K	0.62%	46

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Carmel Capital Partners's PFE Position: Q4 2023 in Review

Carmel Capital Partners sold out of Pfizer (PFE) in Q4 2023, closing a stake of 2,751 shares — an estimated $91.3K sold.

Carmel Capital Partners first reported a position in PFE in Q4 2021 and held it in 8 quarters. The position peaked at $828K in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Carmel Capital Partners reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Carmel Capital Partners sold 2,751 Pfizer shares in Q4 2023, an estimated $91.3K.
Carmel Capital Partners first reported a position in Pfizer in Q4 2021 and held it in 8 quarters.
Carmel Capital Partners's Pfizer position peaked at $828K in Q4 2021.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Carmel Capital Partners's 13F filing for Q4 2023, filed 1 Feb 2024.